NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM8062814 Query DataSets for GSM8062814
Status Public on Apr 30, 2024
Title Allogeneic treated ddH2O rep 3
Sample type SRA
 
Source name skin
Organism Mus musculus
Characteristics tissue: skin
genotype: Balb/c
treatment: ddH2O
Treatment protocol To reflect the clinical situation with treatment only upon clinical signs of cGvHD, treatment was started 21 days after bone marrow transplantation and thus after the first clinically detectable manifestations of cGvHD in allogeneically transplanted mice. The outcome of treatment was analyzed seven weeks after transplantation. Antibodies were given i.p twice a week, with a first loading dose at 20 mg/kg and the following doses at 10 mg/kg. Nintedanib was given at 50 mg/kg p.o. daily.
Growth protocol Recipient mice (BALB/c (H-2d)) with an age of 8 weeks received total body irradiation with 700 cGy. Six hours after irradiation, all BALB/c (H-2d) recipients received bone marrow from either BALB/c (H-2d) in a syngeneic or B10.D2 (H-2d) in an allogeneic transplantation manner.
Extracted molecule total RNA
Extraction protocol Total RNA was extracted from 3mm-diameter area of skin using the Nucleo Spin RNA isolation kit (Macherey-Nagel).
A total amount of 1 μg RNA per sample was used as input material for the RNA sample preparations. Sequencing libraries were generated using NEBNext® UltraTM RNA Library Prep Kit for Illumina® (NEB, USA) following manufacturer’s recommendations and index codes were added to attribute sequences to each sample. Briefly, mRNA was purified from total RNA using poly-T oligo-attached magnetic beads. Fragmentation was carried out using divalent cations under elevated temperature in NEBNext First Strand Synthesis Reaction Buffer (5X). First strand cDNA was synthesized using random hexamer primer and M-MuLV Reverse Transcriptase (RNase H-). Second strand cDNA synthesis was subsequently performed using DNA Polymerase I and RNase H. Remaining overhangs were converted into blunt ends via exonuclease/polymerase activities. After adenylation of 3’ ends of DNA fragments, NEBNext Adaptor with hairpin loop structure were ligated to prepare for hybridization. In order to select cDNA fragments of preferentially 150~200 bp in length, the library fragments were purified with AMPure XP system (Beckman Coulter, Beverly, USA). Then 3 μl USER Enzyme (NEB, USA) was used with size-selected, adaptorligated cDNA at 37 °C for 15 min followed by 5 min at 95 °C before PCR. Then PCR was performed with Phusion High-Fidelity DNA polymerase, Universal PCR primers and Index (X) Primer. At last, PCR products were purified (AMPure XP system) and library quality was assessed on the Agilent Bioanalyzer 2100 system.
 
Library strategy RNA-Seq
Library source transcriptomic
Library selection cDNA
Instrument model Illumina NovaSeq 6000
 
Description Allo_H_3
Data processing Reads were checked and filtered by FastQC and Trimmomatic
Reads were mapped to mouse genome (GRCm39) by Spliced Transcripts Alignment to a Reference (STAR)
Uniquely mapped reads were assigned to annotated genes using the “featureCounts” from R package “Rsubread” (version 1.22.2)
Assembly: GRCm39
Supplementary files format and content: text document containing raw counts all groups of sample
 
Submission date Feb 04, 2024
Last update date Apr 30, 2024
Contact name Jörg Distler
E-mail(s) [email protected]
Organization name University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University
Department Department of Rheumatology
Lab Hiller Research Center
Street address Merowingerplatz 1A
City Düsseldorf
ZIP/Postal code 40225
Country Germany
 
Platform ID GPL24247
Series (1)
GSE255031 Combined inhibition of IL-1, IL-33 and IL-36 signaling by targeting IL1RAP ameliorates skin and lung fibrosis in preclinical models of Systemic Sclerosis
Relations
BioSample SAMN39824635
SRA SRX23531006

Supplementary data files not provided
SRA Run SelectorHelp
Raw data are available in SRA

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap